World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
17212
World Ranking
2913
National Ranking
264

Roland Kolbeck publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Roland Kolbeck sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 158 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Roland Kolbeck D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Roland Kolbeck sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Roland Kolbeck is affiliated with AstraZeneca in the United Kingdom and has contributed extensively to research in medicine, particularly in immunology and pulmonary and respiratory medicine. Their work spans multiple subfields, including physiology, surgery, and epidemiology, with a notable focus on respiratory diseases and immune system pathways.

The scientist's research addresses a variety of topics, including:

  • Neonatal Respiratory Health Research
  • Asthma and respiratory diseases
  • IL-33, ST2, and ILC Pathways
  • Eosinophilic Esophagitis
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory viral infections research
  • Atherosclerosis and Cardiovascular Diseases

Roland Kolbeck has published in several venues frequently, including:

  • European Respiratory Journal
  • PLoS ONE
  • Human Gene Therapy
  • Molecular Therapy - Methods & Clinical Development
  • Cellular and Molecular Immunology

Some of the recent papers include:

  • B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling (2020) in Cellular and Molecular Immunology
  • IL-33-ST2 axis regulates myeloid cell differentiation and activation enabling effective club cell regeneration (2020) in Nature Communications
  • Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE/EGFR signalling complex (2023) in European Respiratory Journal
  • Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue (2020) in European Respiratory Journal
  • Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity (2021) in European Respiratory Journal

Roland Kolbeck has collaborated frequently with several researchers, including:

  • Alison A. Humbles
  • Rania Dagher
  • Katherine J. D. A. Excoffon
  • Maria P. Limberis
  • Jingya Wang

Best Publications

  • Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?

    Martin Kerschensteiner;Eike Gallmeier;Lüder Behrens;Vivian Vargas Leal

  • MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function.

    Roland Kolbeck;Alexander Kozhich;Masamichi Koike;Li Peng

  • Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia

    Michel Laviolette;David L. Gossage;Gail Gauvreau;Richard Leigh

  • Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study

    Mario Castro;Sally E Wenzel;Eugene R Bleecker;Emilio Pizzichini

  • IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE.

    Shu Wang;Jingya Wang;Varsha Kumar;Jodi L Karnell

  • Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs

    Jonathan S Silver;Jennifer Kearley;Alan M Copenhaver;Caroline Sanden

  • Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF

    Tomoya Matsumoto;Stefanie Rauskolb;Martin Polack;Johannes Klose

  • Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma

    William W. Busse;Rohit Katial;David Gossage;Suha Sari

  • IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization

    Derek K. Chu;Alba Llop-Guevara;Tina D. Walker;Kristin Flader

  • Noncanonical Autophagy Is Required for Type I Interferon Secretion in Response to DNA-Immune Complexes

    Jill Henault;Jennifer Martinez;Jeffrey M. Riggs;Jane Tian

  • Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection.

    Jennifer Kearley;Jonathan S. Silver;Caroline Sanden;Zheng Liu

  • Neurotrophin release by neurotrophins: Implications for activity-dependent neuronal plasticity

    Marco Canossa;Oliver Griesbeck;Benedikt Berninger;Gabriele Campana

  • Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond.

    Jodi L. Karnell;Sadiye Amcaoglu Rieder;Rachel Ettinger;Roland Kolbeck

  • Relative Contribution of Endogenous Neurotrophins in Hippocampal Long-Term Potentiation

    Guiquan Chen;Roland Kolbeck;Yves-Alain Barde;Tobias Bonhoeffer

  • Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors.

    H.-P. Hohmann;M. Brockhaus;P. A. Baeuerle;R. Remy

  • Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model

    Sarah L. Rowland;Jeffrey M. Riggs;Susan Gilfillan;Mattia Bugatti

  • Expression of High-Mobility Group Box 1 and of Receptor for Advanced Glycation End Products in Chronic Obstructive Pulmonary Disease

    Nassima Ferhani;Séverine Letuve;Alexander Kozhich;Olivier Thibaudeau

  • IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways.

    Jennifer Kearley;Jonas S. Erjefalt;Cecilia Andersson;Ebony Benjamin

  • Molecular and clinical rationale for therapeutic targeting of interleukin‐5 and its receptor

    N. A. Molfino;D. Gossage;R. Kolbeck;J. M. Parker

  • RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA.

    Cherilyn M. Sirois;Cherilyn M. Sirois;Tengchuan Jin;Allison L. Miller;Damien Bertheloot

  • Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root

    Daniel Teupser;Stephanos Pavlides;Marietta Tan;Jose-Carlos Gutierrez-Ramos

Frequent Co-Authors

Yves-Alain Barde
Yves-Alain Barde Cardiff University
Martin R. Stämpfli
Martin R. Stämpfli McMaster University
Ronald Herbst
Ronald Herbst Biolojic Design
Manel Jordana
Manel Jordana McMaster University
Anthony J. Coyle
Anthony J. Coyle Takeda (United States)
Derek K. Chu
Derek K. Chu McMaster University
Jonas S. Erjefält
Jonas S. Erjefält Lund University
Eicke Latz
Eicke Latz German Rheumatism Research Centre
Peter A. Kiener
Peter A. Kiener AstraZeneca (United Kingdom)
Tomas Mustelin
Tomas Mustelin University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare. One popular route is becoming a psychiatric mental health nurse practitioner. Many students seek out the best online psychiatric mental health nurse practitioner programs which offer strong clinical placements, ensuring hands-on experience alongside theoretical knowledge.

Cost is a major factor, too. There are several affordable options for certification, such as the cheapest online pmhnp certificate programs, making it easier for aspiring professionals to enter the field without a heavy financial burden.

Understanding salary potential is crucial for career planning. Resources detailing dnp salary transparency provide clarity on earnings, helping students make informed decisions about where to study and work.

Additionally, for nurses already certified in family practice, the option to advance through an fnp to acute care np bridge program offers a clear pathway to specialize in acute care, expanding their scope of practice within healthcare systems.

Best Scientists Citing Roland Kolbeck

Trending Scientists

Recently Published Articles